Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Innovative drug classes and advanced delivery systems are transforming the therapeutic landscape for degenerative retinal diseases, including neovascular age-related macular degeneration (nAMD ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with ...

Furthermore, patients on GLP-1s are likely to receive more frequent medical care, and this could have potentially increased nAMD detection rates compared to the control group, Isaacs added.

Intravitreal anti-VEGF agents are linked to a slight increase in the risk for stroke in patients with age-related macular ...

More than twofold increased risk seen for nAMD development in unadjusted and adjusted models. HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists ...